MOROVAN

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: MOROVAN
Generic name: LIDOCAINE
Manufacturer: HONG KONG UNORDERED TRADING CO., LIMITED
Product type: HUMAN OTC DRUG
SPL set ID: 550c8d2d-e0d7-1531-e063-6394a90a374d
SPL ID: 550c8d2d-e0d8-1531-e063-6394a90a374d
Version: 1
Effective date: 2026-06-25
Source export date: 2026-09-28
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:55:46

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		MOROVAN	openfda.brand_name
generic name		LIDOCAINE	openfda.generic_name
manufacturer name		HONG KONG UNORDERED TRADING CO., LIMITED	openfda.manufacturer_name
ndc	package	87800-2624-1	openfda.package_ndc
ndc	product	87800-2624	openfda.product_ndc
ndc11	package	87800262401	derived:openfda.package_ndc
rxcui		1421893	openfda.rxcui
spl id		550c8d2d-e0d8-1531-e063-6394a90a374d	id
spl set id		550c8d2d-e0d7-1531-e063-6394a90a374d	set_id
unii		98PI200987	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Do not use On large areas of damaged skin, blistered skin, or open wounds. When using this product Avoid contact with eyes. If contact occurs, rinse thoroughly with copious amounts of water. Stop use and ask a doctor if Redness, swelling, or allergic reaction develops. Symptoms persist or condition worsens.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.